🟢 Bio Green Med Solution is trading 8.87% up today after amended S-4/A advanced proposed Future NRG acquisition

Bio Green Med Solution is trading 8.87% up now at $0.98 after an amended S-4/A filing advanced its proposed all-stock acquisition of Future NRG, a transaction carrying a reported $2 billion headline valuation.

• The September 11 filing included auditor consent for Future NRG’s financial statements in the registration statement.
• Broader markets are weaker as investors focus on elevated Treasury yields, oil-supply risks, and the Federal Reserve’s policy meeting.
• Trading is live as of September 15, 2026.